Tonix Pharmaceuticals (NASDAQ: TNXP) Stock Slides as Q4 Earnings Disappoint
Tonix Pharmaceuticals (NASDAQ: TNXP) stock fell over 10% in pre-market trading Wednesday after the biopharmaceutical company released fourth-quarter earnings that […]
Tonix Pharmaceuticals (NASDAQ: TNXP) Stock Slides as Q4 Earnings Disappoint Read More »
